പെഗിലേറ്റഡ് ലിപ്പോസോമൽ ഡോക്സോറൂബിസിൻ: ഹൃദയത്തിനുള്ള പാർശ്വഫലം കുറവുള്ള കാൻസറിനുള്ള മരുന്ന് Johnson Francis | August 1, 2025 | General Cardiology | No Comments Related Posts Four ways by which Lipoprotein (a) increases cardiovascular risk No Comments | Jul 3, 2025 इको रिपोर्ट में आई वि सी प्लेथोरा क्या है? No Comments | Jul 26, 2025 Potential options for reducing cardiotoxicity of anthracyclines No Comments | Feb 19, 2024 Commotio cordis No Comments | Apr 17, 2024 About The Author Johnson Francis Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal